The QualityStocks Daily Wednesday, April 17th, 2024

Today's Top 3 Investment Newsletters

360 Wall Street(INVO) $1.8200 +139.47%

QualityStocks(SINT) $0.0373 +62.88%

MarketClub Analysis(EDBL) $6.6600 +46.37%

The QualityStocks Daily Stock List

SINTX Technologies (SINT)

QualityStocks, StockMarketWatch, TradersPro, BUYINS.NET, MarketClub Analysis, Broad Street, StocksEarning, InvestorPlace, Trades Of The Day, The Stock Dork, The Online Investor, StreetInsider, MarketBeat, InvestorIntel and INO Market Report reported earlier on SINTX Technologies (SINT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SINTX Technologies Inc. (NASDAQ: SINT) (FRA: 111N) is an original equipment manufacturing ceramics firm that is engaged in researching, developing, manufacturing and commercializing silicon nitride for non-medical and medical applications in South America, Europe and the U.S.

The firm has its headquarters in Salt Lake City, Utah and was founded 1996 by Ashok C. Khandkar and Aaron A. Hofmann. Prior to its name change in October 2018, the firm was known as Amedica Corporation. It operates in the materials industry, under the chemicals sub-industry and serves consumers from different parts of the globe.

The company is party to a collaboration agreement with Oxford Performance Materials Inc. which entails the development of a silicon nitride composite that will be based off of the solution casting technology by OXPEKK SC. It generates product revenue mainly from the sale and manufacture of spinal fusion products utilized in treating spine disorders.

The enterprise provides ceramic-based solutions for various anti-pathogenic, industrial and medical applications. Its pipeline comprises of silicon nitride coating, silicon nitrite powder, porous and solid silicon nitride products. Silicon nitride is compatible and bioactive across all imaging modalities, which provides patients and surgeons with a preferable alternative to the commonly used materials. Additionally, the enterprise is involved in the development of corrosion-and wear-resistant implant components for knee and hip joint replacements and markets spinal fusion products.

After entering into an agreement with 02TODAY in February 2021, the firm recently sold its first shipment of anti-pathogenic silicon nitride powder which is used in the manufacture of mask filters and face masks. With the pandemic raging on, this collaboration is bound to bring in more revenue as well as attract investors into Sintx.

SINTX Technologies (SINT), closed Wednesday's trading session at $0.0373, up 62.8821%, on 490,259,190 volume. The average volume for the last 3 months is 72.243M and the stock's 52-week low/high is $0.0206/$2.19.

Artificial Intelligence Technology Solutions (AITX)

QualityStocks, MarketClub Analysis, The Street Report, Investors Alley and InvestorPlace reported earlier on Artificial Intelligence Technology Solutions (AITX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Artificial Intelligence Technology Solutions Inc. (OTC: AITX) is focused on delivering robotic and artificial intelligence solutions for monitoring, security and operational needs. The company’s AI technologies are supported by custom cloud and software services and paired with multi-use hardware, which helps to intelligently integrate and automate operational, concierge and security tasks.

The firm has its headquarters in Reno, Nevada and was founded by John B. Crawford in 2010, on March 25. Before changing its name in August 2018 to Artificial Intelligence Technology Solutions Inc., the firm was known as On The Move Systems Corp. The company serves consumers in the U.S. and in particular, automobile fleet administrators and vehicle dealerships.

The company operates through its wholly-owned subsidiaries, one of which is Robotic Assistance Devices Inc. The subsidiary develops unique technology, specifically; mobileware, cloudware, software and hardware, which are used in the development of powerful tools like RADGuard, RADPMC and RADSOC as well as to improve performance in companies.

The firm is also engaged in the provision of mobile electronic services and offers after-market video, audio and electronic upgrades for boats, recreational vehicles and automobiles.

The company recently entered into an agreement with EAGL Technology Inc. for the provision of the latter firm’s gunshot detection system in all present and future RAD devices. The integration of EAGL solutions into the innovative products will not only make the products more popular but also expand their reach into the markets they serve, which will be good for investments as well as the firm’s stock.

Artificial Intelligence Technology Solutions (AITX), closed Wednesday's trading session at $0.0041, up 57.6923%, on 227,739,328 volume. The average volume for the last 3 months is 26,865 and the stock's 52-week low/high is $0.0019/$0.0146.

Reklaim Limited (MYIDF)

QualityStocks, RedChip, and SeriousTraders reported earlier on Reklaim Limited (MYIDF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Reklaim Limited (OTC: MYIDF) (CVE: MYID) is a consumer data and privacy platform that is driven by the evolution of data and privacy.

The firm has its headquarters in Toronto, Canada and was incorporated in 1997, on January 14th by Neil Sweeney. Prior to its name change in November 2021, the firm was known as Killi Limited. It operates as part of the software-application industry, under the technology sector. The firm mainly serves consumers in Canada, the United States, Singapore, Australia, and New Zealand.

The enterprise offers compliant, first-party data to Fortune 500 brands and agencies, platforms, and data firms through which it allows consumers to visit the platform, confirm their identity and unveil data that has been collected and sold on them for years without the consumer's explicit consent. It enables consumers to take back control of this data by setting up a Reklaim account where, should they choose to, consumers can be compensated for using their data or protect it via a suite of privacy tools. The enterprise's platform offers different data segments, which include household information, interests, traits, reading preferences, watching preferences, donation history, and financial information. It reveals various attributes based on the amount or variety of regular internet activities of the consumers, such as reading articles, shopping, managing finances, and streaming platforms.

The company’s latest financial results show a significant surge in annual revenues, with its CEO noting that they remained focused on maintaining full-year profitability and sustaining a robust growth trajectory. This will allow it to seize emerging opportunities and create additional value for its shareholders.

Reklaim Limited (MYIDF), closed Wednesday's trading session at $0.101, off by 6.6543%, on 30,200 volume. The average volume for the last 3 months is 2.922M and the stock's 52-week low/high is $0.02/$0.1575.

Cronos Group Inc. (CRON)

InvestorPlace, Schaeffer's, Kiplinger Today, MarketClub Analysis, StocksEarning, The Street, MarketBeat, Daily Trade Alert, QualityStocks, Trades Of The Day, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, StockEarnings, StockMarketWatch, StreetInsider, BUYINS.NET, The Wealth Report, Zacks, Investopedia, Top Pros' Top Picks, Stock Up Featured, Daily Profit, Cabot Wealth, InvestmentHouse, Jim Cramer, Early Bird, InsiderTrades, The Rich Investor, Wall Street Window, InvestorsObserver Team, VectorVest, Money Morning, 24/7 Trader, TheTradingReport, Small Cap Firm, Stock Gumshoe and InvestorsUnderground reported earlier on Cronos Group Inc. (CRON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

In a fresh lawsuit brought against the U.S. Department of Justice (DOJ) and the U.S. Drug Enforcement Administration (DEA), MMJ BioPharma Cultivation, a marijuana company based in Rhode Island, is seeking to halt an administrative law judge’s review of its application to produce cannabis for research.

The lawsuit contends that DEA director Anne Milgram unlawfully appointed administrative law Judge Teresa Wallbaum. The company argues that this action violates the constitutionality of the process and the decision-maker involved, as well as lacks accountability to the president. The lawsuit names DEA Administrator Anne Milgram, DEA Administrative Law Judge Teresa Wallbaum, the DOJ and U.S. Attorney General Merrick Garland as defendants.

The company submitted its application to legally cultivate cannabis for research in 2018 to create clinical trials medicines addressing conditions such as Huntington’s disease and multiple sclerosis. However, it claims that despite applying five years ago, it has faced delays and uncertainties from the DEA leading to significant negative impacts on its operations, including the inability to expand its workforce and the loss of revenue.

Despite the legal action, Wallbaum stated that given the available facts and unique circumstances, a stay seemed appropriate. Highlighting MMJ’s challenge to the tribunal’s jurisdiction under Axon, which allows federal courts to handle structural challenges, she indicated that this presents a complex issue affecting the DEA’s possibility of success. Moreover, she referred to the Axon court’s decision, underscoring that exposing a party to legal proceedings carried out within an unconstitutional framework could itself amount to legal harm.

During recent committee hearings in Congress, Congressman Earl Blumenauer raised concerns about medical marijuana research and treatment delays. He noted that delays such as MMJ’s had an impact on Biden’s administration.

The company’s president, Duane Boise, condemned the DEA’s action, accusing the agency of impeding cannabis research. He underlined that even while MMJ complies with the law, the DEA has not, which has resulted in hardship for patients in need as a result of inaction on the part of the government.

Attorney Tim Moynahan, who is also the company’s chair, expressed hope that by challenging the DEA’s constitutionality while offering a path for correction, this case would be resolved. He urged the DEA to settle the matter, especially considering MMJ’s crucial role in developing drugs to aid patients with conditions such as Huntington’s disease and multiple sclerosis.

The scheduled hearing before the DEA administrative law judge on April 10, 2024, has been temporarily halted following the filing of the federal lawsuit.

For quite some time, complaints have persisted about the way the DEA handles applications related to marijuana research. The outcome of this lawsuit could play a role in bringing about some needed changes so that companies such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) can face fewer hurdles should they ever require DEA approval for any cannabis study that they wish to undertake.

Cronos Group Inc. (CRON), closed Wednesday's trading session at $2.42, off by 0.819672%, on 3,068,630 volume. The average volume for the last 3 months is 6.582M and the stock's 52-week low/high is $1.64/$2.99.

SMX Security Matters (SMX)

QualityStocks, Broad Street, 247 Market News, The Online Investor, PennyStockScholar, PennyStockProphet and InvestorsUnderground reported earlier on SMX Security Matters (SMX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SMX (Security Matters) (NASDAQ: SMX), a company that integrates chemistry, physics and computer science to give materials memory and create a culture of transparency and trust across multiple industries, has completed the transactions related to $2.2 million private placement. The company filed required forms with the U.S. Securities and Exchange Commission (“SEC”) on April 11, 2024. The forms noted that SMX had completed transactions related to the purchase agreement including issuing and selling to an institutional investor a promissory note and warrants for gross proceeds of approximately $2.2 million, before deducting fees and other offering expenses payable by the company. SMX anticipates using the funds from the agreement to repay amounts owed by the company, as well as for working capital and general corporate purposes. EF Hutton served as the placement agent on the private placement.

To view the full press release, visit

About SMX (Security Matters) Public Limited Company

SMX offers players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy. As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, the company’s platform becomes increasingly attractive. For more information, visit the company website at

SMX Security Matters (SMX), closed Wednesday's trading session at $0.1734, up 11.0826%, on 3,377,709 volume. The average volume for the last 3 months is 33.722M and the stock's 52-week low/high is $0.12/$58.96.

Lucid Group Inc. (LCID)

Green Car Stocks, InvestorPlace, StockEarnings, Schaeffer's, QualityStocks, The Street, MarketBeat, Early Bird, MarketClub Analysis, GreenCarStocks, StocksEarning, Investopedia, INO Market Report, Daily Trade Alert, Trades Of The Day, Kiplinger Today, Money Wealth Matters, The Online Investor, Louis Navellier, The Wealth Report, Zacks, DividendStocks, BillionDollarClub, The Night Owl, Cabot Wealth, Wealth Whisperer, Green Energy Stocks, Top Pros’ Top Picks, InvestorsUnderground, AllPennyStocks, The Stock Dork, Smartmoneytrading and InsiderTrades reported earlier on Lucid Group Inc. (LCID), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lucid Group (NASDAQ: LCID), a company setting new standards for the luxury electric experience with the Lucid Air, America's most awarded new luxury vehicle, has released details about its 2024 Lucid Air Grand Touring. This year’s model features enhancements designed to help people drive farther and charge faster in a broader range of environments and conditions. Enhanced features include an EPA-estimated range of 516 miles, the longest range of any EV in the U.S. market today; more efficiency and more sustainable performance, thanks to the vehicle’s proprietary motor design, battery cell chemistry and thermal characteristics; and an estimated 15%–30% faster DC charging. “The Air Grand Touring is our longest-range car — in fact the longest-range EV available today — and is now further optimized with a multitude of powertrain updates, including the Air Sapphire heat pump," said Lucid CEO and CTO Peter Rawlinson in the press release. “The Air Grand Touring has retained its 516-mile range estimate, achieving this despite more-stringent EPA testing. More importantly, it delivers improved range and efficiency in a broader range of everyday, real-world conditions.”

To view the full press release, visit

About Lucid Group Inc.

Lucid Group has a mission to inspire the adoption of sustainable energy by creating advanced technologies and the most captivating luxury electric vehicles centered around the human experience. The company's first car, the Air, is a state-of-the-art luxury sedan with a California-inspired design. The Lucid Air is assembled at the company’s factories in Casa Grande, Arizona, and King Abdullah Economic City (“KAEC”), Saudi Arabia; deliveries of Lucid Air are currently underway to customers in the United States, Canada, Europe and the Middle East. For more information about the company, visit

Lucid Group Inc. (LCID), closed Wednesday's trading session at $2.42, up 0.833333%, on 12,901,576 volume. The average volume for the last 3 months is 324,177 and the stock's 52-week low/high is $2.35/$8.37.

DeFi Technologies Inc. (DEFTF)

RedChip, QualityStocks and InvestorPlace reported earlier on DeFi Technologies Inc. (DEFTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

DeFi Technologies (CBOE CA: DEFI) (GR: R9B) (OTCQB: DEFTF), a FinTech company establishing itself as the first and only publicly traded company that bridges the gap between traditional capital markets, Web3 and DeFi, today announced a partnership with the Core Foundation and its subsidiary Valour to launch groundbreaking Exchange Traded Products ("ETPs"), including a first-of-its-kind Yield Bearing Bitcoin (BTC) ETP that introduces a new era for Bitcoin as an actively yielding investment.

To view the full press release, visit

About DeFi Technologies Inc.

DeFi Technologies Inc. (NEO: DEFI) (GR: MB9) (OTC: DEFTF) is a financial technology company that pioneers the convergence of traditional capital markets with the world of decentralized finance (DeFi). With a dedicated focus on industry-leading Web3 technologies, DeFi Technologies aims to provide widespread investor access to the future of finance. Backed by an esteemed team of experts with extensive experience in financial markets and digital assets, we are committed to revolutionizing the way individuals and institutions interact with the evolving financial ecosystem. Join DeFi Technologies' digital community on Linkedin and Twitter, and for more details, visit

DeFi Technologies Inc. (DEFTF), closed Wednesday's trading session at $0.5895, off by 4.8887%, on 144,657 volume. The average volume for the last 3 months is 5.506M and the stock's 52-week low/high is $0.0485/$0.726.


Schaeffer's, InvestorPlace, StockEarnings, StocksEarning, QualityStocks, MarketBeat, Trades Of The Day, Daily Trade Alert, BUYINS.NET, Kiplinger Today, The Street, StreetInsider, The Online Investor, FreeRealTime, Early Bird, CNBC Breaking News, Investopedia, MarketClub Analysis, StockMarketWatch and MarketClub reported earlier on SNDL Inc. (SNDL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The possession and use of cannabis is illegal under federal law in the United States. Despite this, many states across the country have legalized the drug for recreational or medical purposes. This comes as public support for legalization continued to increase.

Below are some facts about cannabis in the United States, based on recent data.

Almost 90% of Americans want cannabis to be legalized for recreational or medical use.

A survey conducted by Pew Research Center in January found that 88% of adults in America think cannabis should be legal for recreational or medical use.

More than 50% live in a state where both recreational and medical use is legal.

A data analysis conducted by the Census Bureau found that 54% of Americans live in legal states, while another 74% live in states where cannabis is legal for either medical or recreational use.

The first states to legalize recreational cannabis were Washington and Colorado.

Almost 80% of Americans live in a county with at least one marijuana dispensary.

According to the Census Bureau analysis, there are almost 15,000 marijuana dispensaries across the country. More than 75% of individuals live in states where recreational marijuana is legal while another 23% live in medical states.

The states with the largest number of dispensaries include Oklahoma, California, Michigan, Colorado and Florida.

Support for cannabis legalization has grown greatly over the last 20 years.

A 2023 Gallup survey found that 70% of adults support the legalization of cannabis. This is more than double the number of individuals who supported the drug’s legalization in 2000.

Views on cannabis legalization differ by political party, age, ethnicity and race.

An estimated 71% of adults aged 30 years and younger are in favor of recreational and medical legalization of cannabis. In comparison, 31% of those aged 75 and older support cannabis legalization for recreational and medical use. In addition, 72% of Democrats favor cannabis legalization for both uses while 42% of GOP members favor the drug’s legalization for both uses.

The January survey also found that 65% of Blacks, 59% of Whites and 45% of Asian Americans and Hispanics support the drug’s legalization for recreational and medical use.

About 50% of Americans have used cannabis.

A survey carried out by the National Survey on Drug Use and Health last year found that 50% of Americans have used cannabis before. This is a smaller share than the 64% who have used tobacco products and the 84% who admitted to consuming alcohol.

All these statistics and facts point to the changing perception of marijuana, and enterprises such as SNDL Inc. (NASDAQ: SNDL) are looking forward to the time when the federal prohibition of cannabis finally ends.

SNDL Inc. (SNDL), closed Wednesday's trading session at $1.83, off by 7.5758%, on 7,234,173 volume. The average volume for the last 3 months is 141,282 and the stock's 52-week low/high is $1.25/$2.67.

Cenntro Electric Group Ltd. (CENN)

QualityStocks, GreenCarStocks, TradersPro, Penny Stock and InvestorPlace reported earlier on Cenntro Electric Group Ltd. (CENN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A senior government official has urged President Joe Biden to take steps and prevent cheap Chinese electric vehicles from proliferating the nascent American electric vehicle sector. Chinese EVs are significantly more affordable compared to similar offerings from Western carmakers, thanks to massive subsidies from Beijing.

Billions of dollars in government funding have allowed carmakers in China to sell their battery electric cars at much lower price points than their Western counterparts, giving them what many have termed an unfair advantage. European Union leaders have already launched a probe into the multitudes of cheap Chinese electric vehicles that have been flooding the European Union market in the past several months.

These leaders say that Beijing is lowering electric vehicle prices artificially and making it nigh-impossible for European automakers to compete in local markets. Senate Banking Committee chair Senator Sherrod Brown is of the same opinion. In what are the strongest remarks on the subject from a U.S. lawmaker so far, Brown said Chinese EVs pose an “existential threat” to America’s automotive industry.

The senator’s statement comes more than a month after the White House announced a U.S. investigation into Chinese vehicles to determine if the cars present a risk to national security. According to Brown, the U.S. government cannot allow China to export its “government-backed cheating” to the U.S. auto sector.

On average, battery electric cars are more expensive than gas and diesel-powered cars because many of their components are more expensive. By providing billions of dollars in subsidies to domestic carmakers, China has cut down production costs in its EV industry significantly and allowed its auto industry to develop and sell EVs relatively cheaply.

Since Western carmakers don’t have the same level of support from their governments, they simply cannot compete. In some cases, Western carmakers have lowered their prices to get their vehicles off their lots even if they operate at a loss. If Chinese EVs flood the American market, U.S. automakers will likely face an existential crisis.

President Biden noted in January that he wouldn’t allow Chinese EVs to enter the American market because they were potential national security risks. As per the White House, concerns that Chinese EVs contained technology capable of collecting sensitive data from U.S. drivers and their passengers could force Washington to institute restrictions on Chinese-made EVs.

After more than two decades of strategic planning and major investments, China is now the largest vehicle producer on the globe and is looking to wrestle the top exporter spot from Japan. However, a 27.5% tariff levied on Chinese cars has largely prevented their proliferation in the United States. U.S. Treasury secretary Janet Yellen also said during a recent trip to China that the Biden administration wouldn’t allow Chinese vehicle imports to flood the U.S. market.

Other makers of EVs that aren’t headquartered in the U.S. such as Cenntro Electric Group Ltd. (NASDAQ: CENN) will be observing how the dispute over China-made EVs plays out because it could ease some of the challenges that manufacturers face in breaking even amid such stiff competition.

Cenntro Electric Group Ltd. (CENN), closed Wednesday's trading session at $1.48, up 0.680272%, on 67,809 volume. The average volume for the last 3 months is 55.566M and the stock's 52-week low/high is $1.00/$5.001.

Nio Inc. (NIO)

Green Car Stocks, InvestorPlace, Schaeffer's, MarketClub Analysis, The Street, MarketBeat, StocksEarning, QualityStocks, StockEarnings, Daily Trade Alert, Trades Of The Day, Kiplinger Today, The Online Investor, Early Bird, INO Market Report, Zacks, StreetInsider, StockMarketWatch, BUYINS.NET, Cabot Wealth, FreeRealTime, GreenCarStocks, TipRanks, Money Wealth Matters, Wealth Insider Alert, CNBC Breaking News, AllPennyStocks, The Wealth Report, InvestorsUnderground, Daily Wealth, Earnings360, Investopedia, wyatt research newsletter, Louis Navellier, TradersPro, Energy and Capital, BillionDollarClub, Wealth Daily, CRWEWallStreet, TopPennyStockMovers, Top Pros’ Top Picks, MarketClub, The Night Owl, Investors Alley, Stock Market Watch, Smartmoneytrading, Green Energy Stocks, Jim Cramer, InvestorsObserver Team, InvestorIntel and Top Pros' Top Picks reported earlier on Nio Inc. (NIO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Chinese automotive company Nio Inc. (NYSE: NIO) has raised more than $5 billion in investor capital so far, and its stock is one of the most searched on Despite these positive moves, Nio shares had a -20.1% return during the past four weeks compared to the +1.6% gain seen by the Zacks S&P 500 Composite. The Zacks Automotive–Foreign industry category where the company’s shares are listed also saw a 1.2% gain over the same period.

Although it didn’t pioneer the idea of battery swapping as an alternative to charging battery electric vehicles (BEVs), Chinese electric vehicle company Nio was the first major company to roll out battery swapping stations alongside regular charging stations. With more than 2,300 installed battery swap stations and plans to roll out 1,000 more, the EV company currently has the largest battery swap network on the globe. As battery swapping essentially grants EV drivers the same speed and convenience as refueling a petrol or diesel-powered vehicle, Nio soon attracted significant investor attention.

So, why are Nio shares performing at their current level, and how will they fare in the near- and medium-term future? According to an analysis by, Nio will suffer a loss of $0.31 per share this quarter, a +26.2% change compared to the company’s performance in the same quarter last year.

The Zacks Consensus Estimate has also seen a -75% change over the past month. Zacks says that Nio’s -$1.26 consensus earnings estimate for the ongoing fiscal year indicates a +28% change from last year with the estimate changing by -10% over the past 30 days. Furthermore, Zacks notes that the Chinese automaker’s -$0.83 consensus earnings estimate pointed to a +34% change compared to expected reports with a +35% change in the past month.

The Zacks Rank, a proprietary stock tool used by to offer more conclusive predictions of stock price directions, rates Nio shares at no. 4 (sell) thanks to the size of the recent consensus estimate change.

Nio’s $1.48 billion consensus sales estimate for the ongoing quarter points to a -4.7% year-over-year change while $9.21 billion and $15.36 billion consensus sales estimates for the current fiscal year and the next fiscal year point to +18.3% and +66.8% changes respectively. Nio’s reported revenue for the last quarter also reached $2.41 billion, 3.4% more than the same quarter last year while its EPS was at -$0.45 compared to -$0.51 compared to the previous year.

Nio Inc. (NIO), closed Wednesday's trading session at $3.91, up 2.6247%, on 38,766,961 volume. The average volume for the last 3 months is 7.673M and the stock's 52-week low/high is $3.71/$16.18.

Bit Digital Inc. (BTBT)

QualityStocks, StocksEarning, MarketClub Analysis, Schaeffer's, TradersPro, InvestorPlace, StockEarnings, MarketBeat, CryptoCurrencyWire, Wealth Daily, InvestorsUnderground, Early Bird and Daily Trade Alert reported earlier on Bit Digital Inc. (BTBT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The cryptocurrency market experienced a significant downturn on April 12, 2024, coinciding with the opening of the stock market. Bitcoin (BTC) saw a considerable drop in value, plummeting by more than $4,000 to $66,440. Similarly, Ethereum witnessed a decline of 9% during the same period, reaching $3,216, while Dogecoin experienced a sharp decline of 14.2%.

The downward trend began early in the day but intensified around noon, with minor decreases escalating into double-digit declines across several cryptos. Although no major developments were reported in the crypto sphere on that day, such volatility often occurs toward the weekend, as was the case this time.

The past week presented few positive developments for cryptocurrencies. Higher-than-anticipated inflation figures released earlier led to an uptick in interest rates and a downturn in growth and technology stocks, which historically have correlated with declining cryptocurrency values. However, it took some time for the market to digest this news.

Additionally, Uniswap received a Wells notice from the U.S. Securities and Exchange Commission (SEC) indicating potential legal action against the crypto. Regulatory ambiguity has been a persistent issue, with investors seeking clarity on legal boundaries. The SEC’s track record of pursuing legal action against prominent players such as Coinbase and XRP further compounds the uncertainty surrounding the outcomes of such actions.

It’s not unexpected that some investors choose to cash in their profits during a peak, given the uncertainty surrounding crypto regulations and the potential for legal action.

Once a crash commences, it can be exacerbated by leverage within the cryptocurrency market. Traders often hold leveraged positions, and liquidity tends to decrease over weekends, potentially exacerbating the situation on Fridays.

According to data from, long positions worth $668 million were liquidated within a few hours on Friday alone. While liquidations are not uncommon, such a significant volume within a few hours is unusual. What distinguishes this downturn is its widespread impact. Not only are major cryptocurrencies such as Dogecoin, Bitcoin and Ethereum affected, but smaller tokens are also experiencing steep declines.

Although volatility is inherent to the cryptocurrency market, the magnitude of this decline is notably high, and it remains uncertain what could arrest this trend. In recent months, the market has seen substantial inflows of capital into Bitcoin spot ETFs, driven by speculative activity and amplified by leverage. While this trend has buoyed prices, a reversal could spell trouble for crypto values. As earnings season commences and interest rates rise, investors may seek safer alternatives amid what could be a particularly tumultuous period for the industry.

Industry actors such as Bit Digital Inc. (NASDAQ: BTBT) will be watching how the market responds over the coming weeks and months in light of the evolving macroeconomic realities.

Bit Digital Inc. (BTBT), closed Wednesday's trading session at $1.81, off by 0.549451%, on 4,448,390 volume. The average volume for the last 3 months is 17.313M and the stock's 52-week low/high is $1.61/$5.27.

Meta Platforms Inc. (META)

The Street, Zacks, InvestorPlace, Early Bird, Investopedia, Schaeffer's, MarketClub Analysis, MarketBeat, The Online Investor, Kiplinger Today, INO Market Report, Cabot Wealth, Louis Navellier, TipRanks, The Night Owl, Top Pros' Top Picks, Money Wealth Matters, Trading Tips, The Daily Market Alert, TradersPro, AllPennyStocks, DividendStocks, Eagle Financial Publications, Investment House, Daily Wealth, Trading with Larry Benedict, InvestorIntel, The Wealth Report, Market Trends, Smartmoneytrading, CNBC Breaking News, QualityStocks, FreeRealTime, Contrarian Outlook, InsiderTrades, Investing Breakout, TradingPub, Rick Saddler, Smart Investing Society, The Stock Dork, bullseyeoptiontrading, Jon Markman’s Pivotal Point, TradeSmith Daily, Trade Out Loud,, Investing Daily, wyatt research newsletter, Chaikin Analytics, The SmartMoneyTrading, 360 Wall Street, The Investing Insider, Empire Financial Daily, empirefinancialresearch, Hit and Run Candle Sticks, Investor News, Inside Trading, Mind Over Markets, Trading Pub, Investor's Business Daily, 1 2 3 Trade Option, OTC Stock Review and iDigital Market reported earlier on Meta Platforms Inc. (META), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

According to a recent report, financial service companies such as Morgan Stanley and Goldman Sachs have been testing AI tools that could leave some individuals unemployed. Investment companies and banks globally are currently considering the replacement of entry-level positions with AI, with more than one-half of these positions set for scrapping. This may transform how companies hire new employees entirely as well as how they deliver the technology used by their employees.

Goldman Sachs estimates that about 300 million workers may be affected by the adoption of artificial intelligence in the workplace.

One of the primary reasons why artificial intelligence may impact entry-level financial positions is its potential to automate information processing, which makes up a huge part of many people’s job descriptions. Additionally, most employees in these positions experience burnout because of the repetitive work and long hours, which make it less attractive to graduates.

Currently, financial service organizations use different automation technologies, from basic job schedulers to workload automation tools. An SMA Technologies report found that modern technologies such as intelligent process automation using artificial intelligence or intelligent document processing are already being used by 33% and 27% of firms, respectively.

Generative artificial intelligence is also transforming the workplace, with most organizations using it to supplement employee tasks. Experts expect this to change as AI adoption grows, with the first positions to be affected being chief information officers in the financial industry.

A report by the Burning Glass Institute and the Society for Human Resource Management expects that financial services, along with market research and law, are the main industries that shall be impacted by the implementation of generative artificial intelligence. The report highlighted that the most notable companies affected included Northwestern Mutual, Bank of America and Morgan Stanley.

For chief information officers, it may mean fewer employees to oversee and organize. Adopting AI may also mean new and different challenges for companies. In the short-term, generative artificial intelligence in financial services will facilitate the improvement of efforts to mitigate risk, further automation of financial analyses and financial operation optimization.

This is according to a Deloitte report, which noted that generative AI’s ability to process huge amounts of data and produce new content holds great promise for disruptions that couldn’t be predicted.

When asked about their companies’ plans to implement artificial intelligence or how it may change their hiring plans, representatives from Morgan Stanley, JP Morgan Chase and Goldman Sachs declined to respond.

Job losses aren’t only going to be seen in the financial services sector. It is likely that major tech companies such as Meta Platforms Inc. (NASDAQ: META) are already employing fewer workers than they would have required if the tech at their disposal wasn’t in the picture.

Meta Platforms Inc. (META), closed Wednesday's trading session at $494.17, off by 1.1185%, on 12,193,743 volume. The average volume for the last 3 months is 314,625 and the stock's 52-week low/high is $207.13/$531.4899.

The QualityStocks Company Corner

FingerMotion Inc. (NASDAQ: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (NASDAQ: FNGR) .

FingerMotion (NASDAQ: FNGR), a mobile services and data company, through its contractually controlled entity, Shanghai JiuGe Information Technology Co. Ltd., is facilitating the expanded use of the Da Ge app. According to the announcement, the company is entering into arrangements with certain electric vehicle ("EV") charging station providers in China that will allow owners of electric vehicles who have subscribed to the Da Ge app to locate and charge their cars. The arrangements are with Jiangsu YKC and Shanghai Anyo Charging Technology Co. Ltd, which operates more than 400,000 charging terminals for electric vehicles. According to the announcement, the Da Ge app will integrate with both Jiangsu YKC and Anyo Charging apps, allowing Da Ge users to access direct connections at these terminals; the agreement should provide Da Ge access to the growing Chinese EV market. FingerMotion launched the Da Ge app earlier this year. The app, which currently has 650,000 subscribers, is designed to connect subscribers with independent service stations providing car washing, fine car detailing, paint protective films, color changing and maintenance; so far 20,000 car-care service stations have been onboarded with the app with increased numbers projected by the end of the year. "We are excited to collaborate with both Jiangsu YKC and Anyo Charging and believe this will be a very positive mutually beneficial arrangement," said FingerMotion CEO Martin Shen in the press release. "This is a big step in further monetizing our Da Ge app and giving our subscribers a product that really facilitates the use of electric charging stations in major cities across China. . . . Future Da Ge product offerings may include the company's Top Up and Recharge service, car accessories, and possibly health and auto insurance, which could double our total subscriber numbers by FY 2026."

To view the full press release, visit

FingerMotion Inc. (NASDAQ: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Wednesday's trading session at $3.12, up 0.160514%, on 362,868 volume. The average volume for the last 3 months is 525,916 and the stock's 52-week low/high is $1.28/$7.97.

Recent News

Freight Technologies Inc. (NASDAQ: FRGT)

The QualityStocks Daily Newsletter would like to spotlight Freight Technologies Inc. (NASDAQ: FRGT).

Freight Technologies (NASDAQ: FRGT) ("Fr8Tech") is a technology company whose custom-developed, industry-leading Fr8App freight-matching platform offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company has announced that it was selected by Grupo Solave for cross-border logistics services. Solave, recognized for its leadership in the blue agave market and a reputable tequila producer for notable brands, aims to benefit from optimized logistics and supply chain efficiency through Fr8App's platform. "We are thrilled to take on the role of logistics solutions provider for Solave, applying our advanced platform and extensive network to meet their specific logistics needs," said Javier Selgas, CEO of Fr8App. "Tequila is one of the most popular spirits in the world, and sales are expected to grow approximately 6% annually over the coming decade. We are proud to serve the marketplace of this iconic spirit within Mexican heritage and are positioned to support the logistic requirements of its growth."

To view the full press release, visit

Freight Technologies Inc. (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process, providing a platform for B2B cross-border shipping in the NAFTA region. The company’s mission is to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road shipping.

Freight Technologies, formerly known as Hudson Capital Inc., assumed its current name and ticker symbol on May 27, 2022. Its primary operating subsidiary and its marketplace are known as Fr8App, and it conducts operations throughout North America under the names of Fr8App and/or Freight App. The company is headquartered in Houston, Texas, with multiple locations across the U.S. and Mexico.

The Fr8Tech Solutions Suite

Fr8Tech leverages artificial intelligence to provide cloud-based platforms aimed at automating the over-the-road transportation process, effectively reducing human touch points and expediting load booking times. The company’s suite of solutions includes:

  • Fr8app – A B2B marketplace powered by AI and Machine Learning offering a real-time broker portal to connect shippers with qualified carriers
  • Fr8Radar – A tracking solution providing shippers and carriers real-time locational data via Fr8app’s mobile solution or through integration with third-party GPS alternatives
  • Fr8TMS – A transportation management system designed to help shippers manage their freight and all of the documents involved in shipping transactions, including invoices, customs documents, confirmation rates and proof of deliveries
  • Fr8FMS – A fleet management system allowing transportation companies to better manage their fleets, reduce operational costs and provide better service to their customers
  • Fr8Data – A data solution offering real-time dashboards and reports to shippers and carriers in an effort to increase visibility and control while supporting better business decisions
  • Fr8Fleet – A platform that provides private fleet management, enabling large corporate shippers to purchase dedicated capacity secured by Fr8app in exchange for a fixed fee

Commitment to the Environment

Through its core focus on technology, Fr8Tech seeks to reduce the carbon footprint of the logistics industry. Its solutions aim to minimize empty miles for transportation firms and reduce overall paper consumption.


Fr8University is an educational program offering classroom and on-the-job training for Fr8Tech team members. Through the program, employees learn in-depth business fundamentals and applications along the truckload freight industry value chain.

Led by corporate educator Mario Mena, Fr8University is designed as an investment in the company’s human capital, providing an opportunity to communicate Fr8Tech’s corporate culture while accelerating operational growth.

Market Outlook

Fr8Tech’s established foothold in Mexico is key to its current efforts to promote sustainable growth in the cross-border shipping industry. Ongoing disruption in U.S.-Chinese trade relations have strengthened Mexico’s status as the largest trading partner of the U.S., with cross-border annual freight spending estimated at $385 billion according to data from the U.S. Department of Transportation. Annual domestic shipping in Mexico is estimated at $34 billion, while annual domestic shipping in the U.S. is estimated to total $732 billion.

Despite the size of this industry, fragmentation and inefficiencies prevail in the space. Thousands of legacy brokers, tens of thousands of shippers and hundreds of thousands of carriers still rely on outdated systems to arrange transport, spending hours on the phone negotiating pricing, waiting days to find trucks and drivers, preparing and printing forms, and operating without tracking or visibility. Add in cross-border complexity relating to customs and additional paperwork, and you have an industry ripe for technological disruption.

Fr8Tech’s recent revenue growth trends have highlighted the company’s efforts to capitalize on this opportunity. In 2021, Fr8Tech achieved revenues of $21.5 million, marking a year-over-year increase of 134%. The company issued revenue guidance for fiscal 2022 of $40 million in a February 9, 2022, press release, which would account for a further 86% year-over-year increase.

Management Team

Javier Selgas is CEO and a Director of Freight Technologies Inc. and Freight App Inc. He brings to the company over 15 years of experience developing technology and digital marketing strategies, including serving as Country Manager for Osigu, Spain, and as head of AJEgroup’s IT division for the Asia-Pacific region. Prior to joining Fr8Tech, Mr. Selgas founded digital marketing agency Lanzadera Online. He has also served as an IT consultant to major corporations, including Endesa and Ibermatica.

Mike Flinker is President of Fr8Tech. He has over four decades of experience in the transportation industry, with 30+ years focused on cross-border logistics. Prior to joining Fr8Tech, Mr. Flinker founded FLS Transportation, the largest cross-border logistics company in Canada. He also previously held positions with Clarke Transport Inc., Canadian Pacific and Reimer Express Inc. (a division of Roadway Express).

Paul Freudenthaler is the company’s CFO and Secretary to the company Board. He has over 30 years of financial expertise, having previously served as CFO for several leading companies across multiple countries, including Macquarie in Mexico, Old Mutual in Latin America and Ascentium Capital in the U.S. Mr. Freudenthaler’s experience include leadership roles from which he guided IPOs and M&A transactions.

Luisa Lopez is COO of Fr8Tech. She brings to the company 25+ years of management experience in logistics, supply chain, operations and customer service. Ms. Lopez previously served as a Director of Landstar, where she was responsible for commercial and client development strategies in the Mexican market. Additionally, she managed more than 2,000 transport units specialized in staff and school mobility while with Traxion in Mexico.

Freight Technologies Inc. (NASDAQ: FRGT), closed Wednesday's trading session at $0.93059, up 7.6822%, on 340,335 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $7.97/$.

Recent News

PaxMedica Inc. (NASDAQ: PXMD)

The QualityStocks Daily Newsletter would like to spotlight PaxMedica Inc. (NASDAQ: PXMD).

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has received an urgent request from the Ministry of Health ("MOH") of Malawi requesting emergency access to IV suramin. According to the announcement, Malawi officials requested the suramin in efforts to avert a potential humanitarian crisis brought on by dwindling supplies of drugs used in that region of Africa; the drug is used specifically to treat the most severe form of African sleeping sickness. Last week, PaxMedica completed execution of its three pivotal registration/validation batches of PAX-101 (an IV form of suramin) in preparation for a future NDA submission to the U.S. Food and Drug Administration ("FDA") as an orphan designated drug. With that in mind, PaxMedia has brought this emergency request to the FDA's attention to determine potential impact, if any, on the company's development program and NDA submission plans for PAX-101. "Receiving this request from the Ministry of Health of Malawi serves to emphasize, not only the challenging situation faced by the countries in the most vulnerable zone for the fatal disease, TBr HAT, it speaks to the continued need for suramin as the standard of care in treating stage 1 of the infection, using what's known as the Malawi dosing protocol, which they have used in an effort to save lives in that region for nearly 100 years," said PaxMedica chair and CEO Howard Weisman in the press release. "[The] FDA has agreed that having more than one global manufacturer of drugs like suramin could provide public health benefit by creating multiple supply chains and would help ensure a steady supply of the drug product. . . . PaxMedica is in the process of responding to the Malawi Ministry of Health's request and is in contact with regulatory authorities in both the U.S. and Malawi with an intention to help with today's emergency, as well as to work with the FDA to determine the best path forward to submit the PAX-101 NDA for regulatory approval, as well as to potentially qualify for a Priority Review Voucher under the Neglected Tropical Disease Priority Review Voucher Program, which could provide PaxMedica resources to help ensure a steady supply of suramin to these endemic regions."

To view the full press release, visit

PaxMedica Inc. (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (APTs) for the treatment of Autism Spectrum Disorder (ASD) and other serious conditions with intractable neurologic symptoms.

The company’s lead programs are focused on ASD, for which there are currently no approved pharmacologic treatments that target its cause and symptoms. Currently used treatments only address the symptoms of the condition, rather than targeting the pathophysiology itself.

PaxMedica is on a promising path to address these unmet medical needs, bringing hope to millions. Anti-purinergic therapies target the excess production of purines in cells. An overexpression of purines can offset homeostasis and result in an overproduction of cellular adenosine triphosphate, the main energy molecule in all living cells.

The company is headquartered in Tarrytown, New York.

Product Pipeline

PaxMedica is building a robust pipeline of products targeting ASD and related neurodevelopmental conditions. The company’s lead product in development may help eliminate, reduce or modulate some of the more troublesome aspects of ASD. That would open the potential for people with autism to integrate their behavior with others more successfully and improve their lives.

PaxMedica’s lead programs, PAX-101 and PAX-102, utilize the company’s proprietary source of suramin sodium, a broadly acting anti-purinergic therapy that has been known for over 100 years. Its current pipeline includes:

  • PAX-101 (IV Suramin) for ASD – PAX-101 completed a Phase 2B study for ASD in 2021. Suramin is a broadly acting APT and has reported positive results from a dose range study. The results of PaxMedica’s Phase 2B study, which targeted 52 subjects across six sites in South Africa, were presented to AACAP in October 2021.
  • PAX-102 (Intranasal Suramin) – PaxMedica has developed a proprietary intranasal formulation of suramin that is currently being evaluated in ASD and other neurodevelopmental conditions.
  • PAX-101 for HAT – Given suramin’s historical use as a treatment for Human African Trypanosomiasis (HAT), or African Sleeping Sickness, the company is also developing PAX-101 as a treatment for HAT. PaxMedica’s most advanced program is the pursuit of PAX-101 for early-stage East African HAT.
  • Selective APTs – PaxMedica has conducted several preclinical studies to evaluate other APTs that are more selective to specific purinergic receptors and may offer additional benefits over suramin.

Market Opportunity

According to a report by Fortune Business Insights, a leading global market research company, the global ASD therapeutics market was estimated at $1.93 billion in 2022 and is projected to grow from $2.01 billion in 2023 to $3.42 billion by 2030, a CAGR of 7.9% over the forecast period. As there is no current treatment for the core symptoms of autism, PaxMedica believes the addressable market for PAX-101, if approved, could greatly exceed these forecasts.

Autistic disorder, Asperger’s Syndrome and Pervasive Development Disorder are the three main types of ASD, affecting millions of people globally. A 2020 report by the U.S. Centers for Disease Control & Prevention estimated that one in 36 children in the U.S. have been diagnosed with autism disorder.

Several factors are expected to contribute to market growth prospects. A growing prevalence of the condition globally and rising awareness coupled with available treatment options are key factors expected to drive ASD therapeutics market growth during the forecast period. Growing investment in R&D to find effective treatments is also expected to fuel global market growth.

Management Team

Howard Weisman is Chairman and CEO of PaxMedica. He has been a founder and CEO of several specialty pharma and medical device companies. Most recently, he was executive chairman and co-founder of Sofregen, a biotech company. He also served as CEO and president of Seventh Sense Biosystems, a medical device development company. He also was founder, chairman and CEO of EKR Therapeutics, a specialty pharmaceutical company, and founder and COO of ESP Pharma, a company focused on cardio and neurovascular products. He has a bachelor’s degree in chemistry from Rutgers University.

David Hough, M.D., is Chief Medical Officer at PaxMedica. He is a neuroscience clinical development consultant who previously served as vice president at Janssen Research and Development and in various leadership roles over 17 years. Most recently, he was the compound development team leader for SPRAVATO® for treatment-resistant depression. Prior to that, he was the schizophrenia disease area leader. He played a pivotal role in the development programs for oral INVEGA®, INVEGA SUSTENNA® and XEPLION® for schizophrenia. He is a graduate of West Point and is board certified in psychiatry.

Stephen Sheldon is COO and CFO at PaxMedica. He has served as CEO of Thailand-based specialty healthcare company Indochina Healthcare Co. Ltd. since 2015. Previously, he was a consultant for PricewaterhouseCoopers Healthcare Advisory in the Chicago office. He was responsible for developing specialty pharmacy patient programs, strategy development for specialty products and compliance programs. He has an MBA from Thunderbird School of Global Management and a bachelor’s degree in computer science and visual arts from Bowdoin College.

PaxMedica Inc. (NASDAQ: PXMD), closed Wednesday's trading session at $0.7999, up 21.197%, on 3,039,220 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.372/$38.9283.

Recent News

Clene Inc. (NASDAQ: CLNN)

The QualityStocks Daily Newsletter would like to spotlight Clene Inc. (NASDAQ: CLNN).

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, and its wholly owned subsidiary Clene Nanomedicine Inc., announced that results from a phase 2 Visionary-MS long-term extension ("LTE") study have been presented at the 2024 American Academy of Neurology ("AAN") annual meeting. The data, which demonstrates improved clinical, functional and structural outcomes associated with daily oral dosing of CNM-Au8 30 mg. for up to three years of treatment, was presented by Dr. Michael Barnett, MBBS, FRACP, FRCP, PhD, from the University of Sydney. The new long-term results from the clinical trial indicate the repair and remyelinating effects of CNM-Au8 treatment in patients, results that further enhance the trial's findings from the double-blind period of the study. Barnett noted that results from the VISIONARY-MS trial "provide clear impetus" for a definitive phase 3 study. "Observing such a profound clinical benefit with corresponding improvements in physiologic measures utilizing a mechanism that does not target immune system modulation has never been demonstrated in prior multiple sclerosis trials," said Clene head of medical Dr. Benjamin Greenberg in the press release. "This is a very exciting data set that gives hope to the millions of people who are suffering from this disabling disease."

To view the presentation, visit

To view the full press release, visit

Clene Inc. (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis (MS).

Its lead drug candidate is CNM-Au8®, an oral suspension developed to restore neuronal health and function by increasing energy production and utilization by driving critical cellular energy producing reactions that enable neuroprotection and remyelination to increase neuronal and glial resilience to disease-relevant stressors. CNM-Au8 is being studied in various clinical trials, including the Harvard/MGH Healey ALS Platform clinical trial for patients with ALS; RESCUE-ALS, a completed proof-of-concept clinical trial in patients with early symptomatic ALS; the REPAIR trials, completed target engagement clinical trials showing brain energy metabolite change with CNM-Au8; and a completed MS clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing MS. The company also has a nanotherapeutic platform of drug discovery.


CNM-Au8, Clene’s lead asset, is a highly concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. Multiple pathogenic insults contribute to neuronal death. Mitochondrial dysfunction and NAD+ decline is a common final pathway in neurodegeneration, with NAD+ as a critical determinant of cell survival and function. CNM-Au8’s catalytic mechanisms target the energetic deficits, oxidative stress and accumulation of misfolded proteins that are common to many neurodegenerative diseases.

The unique catalytic mechanism of action of CNM-Au8 is hypothesized to act as a neuroprotective and remyelinating therapy in neurodegenerative disease states in order to: (1) drive, support and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed and/or damaged cells, (2) directly catalyze the reduction of harmful, reactive oxygen species (“ROS”) and (3) promote protein homeostasis via activation of the heat shock factor-1 pathway, recognized to dampen the cytotoxicity caused by misfolded and denatured proteins, which are known to occur ubiquitously in neurodegenerative diseases.

CNM-Au8 is used in combination with other agents, has no known drug-drug interactions, and is designed to improve function and survival. The clinical effects of both function and survival were seen in its clinical ALS trials, as earlier announced.

More than 500 estimated years of collective exposure across ALS, MS, and Parkinson’s disease participants in CNM-Au8 clinical trials and Expanded Access Protocol (compassionate use) programs have been recorded without any observed safety signals.

CNM-Au8 is a federally registered trademark of Clene Inc. Clene, based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland, began in 2013.

Market Opportunity

ALS is the most prevalent adult-onset progressive motor neuron disease, affecting approximately 30,000 people in the U.S. and an estimated 500,000 people worldwide, with a life expectancy of typically three to five years. Clene estimates that global ALS treatment sales will be greater than $1 billion annually within the coming few years. Additional treatments affecting daily function and survival remain the market need.

Additionally, there are more than 2 million MS patients globally, and Clene estimates the market size to be worth more than $23 billion annually. While the MS community has been successful at limiting relapses, non-relapsing MS patients continue to clinically deteriorate even while receiving effective immunomodulatory disease-modifying therapies (“DMTs”). A critical unmet medical need remains for therapeutic interventions that protect neuronal function and myelin health independent of immunomodulation to address progression independent of relapse activity.

Management Team

Robert Etherington is President, Director and CEO of Clene. He has more than 30 years of sales, marketing and leadership experience in the pharmaceutical industry. Prior to joining Clene, he worked at Actelion Pharmaceuticals, the largest biopharma company in the European Union prior to its acquisition by Johnson & Johnson in 2017, where he led that company’s U.S. commercial operations. He began his pharmaceutical sales and marketing career at Parke-Davis, a division of Pfizer, where he rose to the position of Team Leader overseeing the drug Lipitor.

Mark Mortenson is Chief Science Officer at Clene. He is co-inventor of the technology platform developed to produce the company’s therapeutics. He is the inventor or co-inventor on 32 other U.S. patents and hundreds of corresponding international patents. He is a former chief patent counsel responsible for 5,500 U.S. and international patents and patent applications. He holds bachelor’s degrees in physics and ceramic engineering from Alfred University, a master’s degree in materials science from Penn State University and a J.D. from George Washington University.

Benjamin Greenberg, M.D., MHS, FAAN, is Head of Medical at Clene. He is an internationally recognized expert in disorders of the central nervous system. He is currently professor of neurology and Vice Chair of Clinical and Translational Research in the department of Neurology at University of Texas Southwestern Medical Center in Dallas. He holds a bachelor’s degree from Johns Hopkins, a master’s degree in molecular microbiology and immunology from the Johns Hopkins School of Public Health and graduated from Baylor College of Medicine. He served residency in neurology at The Johns Hopkins Hospital.

Morgan R. Brown is CFO at Clene. He has more than 30 years of finance and accounting experience, with 23 years at biotech, pharmaceutical and medical device companies. He has served in similar roles at Lipocine Inc., Innovus Pharmaceuticals, World Heart Corp., Lifetree Clinical Research and NPS Pharmaceuticals Inc. He previously worked at accounting firm KPMG. He is a CPA with a bachelor’s degree in accounting from Utah State University and an M.S. in business administration from the University of Utah.

Clene Inc. (NASDAQ: CLNN), closed Wednesday's trading session at $0.3396, up 9.5484%, on 9,883,740 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.25/$1.09.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

Last week, Graphjet Technology (NASDAQ: GTI) revealed its plans to construct an artificial graphite manufacturing facility in Nevada. The company develops patented technologies for the sustainable production of graphene, graphene-based anode materials and graphite from agricultural waste. The facility will be the first-of-its-kind in the United States and will have the capacity to recycle up to 30,000 metric tons of agricultural waste, with an annual production aim of 10,000 metric tons of artificial graphite. This is expected to be able to support production of batteries to power over 100,000 electric cars annually. Other companies, such as Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF), are focusing on extracting natural graphite to address the market that prefers the natural form over the synthetic version of this critical mineral.

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.


Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Wednesday's trading session at $0.0891, up 6.5789%, on 8,393 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.063/$0.72.

Recent News

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF)

The QualityStocks Daily Newsletter would like to spotlightFathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF).

Electric vehicles are expected to account for over 50% of automobile sales in 2040, driving a six-fold increase in global nickel demand

Fathom Nickel has looked to capitalize on the world's ambitions for a carbon-neutral future through the exploration and development of two promising nickel deposits located within Canada's Saskatchewan province

The site of historic exploratory and mining activity during the 1960's, initial exploration work across both the Albert Lake and Gochager Lake projects have found great potential in terms of resource and mineral yields

Forecasts suggest that by 2040, electric vehicles ("EVs") will comprise over 50 percent of annual passenger vehicles sales, as manufacturers and customers transition to cleaner forms of transportation in a bid to limit and curb the harmful emissions currently contribution to global warming ( In turn, the surge in electric vehicle manufacturing and sales have significantly escalated the demand for crucial raw material inputs such as nickel within the electric vehicle supply chain; a recent report has suggested that global nickel demand is poised to increase six-fold as of 2030, largely because of the burgeoning electric vehicle market. Whilst this scenario has presented an array of growth prospects within the nickel mining and refining sectors, it has also presented its own challenges, namely in terms of the environmental impact of mining operations as well as geopolitical issues related to supply chain security. Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), a Calgary-based Canadian natural resource development and exploration company has sought to cater to the ongoing energy transition through the exploration and development of high-grade nickel sulfide developments. Nestled within the prolific Trans Hudson Corridor in Canada's Saskatchewan province, Fathom Nickel's two sites, namely – the Albert Lake project and the Gochager Lake project respectively have played host to historic artisan mining operations, with Fathom Nickel now seeking to build upon the prior activity.

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is a Canadian natural resource development and exploration company that targets high-grade nickel sulfide discoveries for use in the rapidly growing global electric vehicle (EV) market. The company has a portfolio of two high-quality exploration projects located in the prolific Trans Hudson Corridor in Saskatchewan.

Led by a management team with more than 100 years of combined mining and exploration experience, Fathom believes in a continuing bright outlook for nickel and its increasing use in the manufacturing of batteries needed for energy storage in the high-growth renewable energy and EV industries. The company’s modern approach to exploration has yielded significant new nickel discoveries.

Fathom is headquartered in Calgary, Alberta.


The Albert Lake Project

The Albert Lake Project comprises 90,460 hectares of lands located in north-central Saskatchewan, with over 80,000 hectares currently unexplored. The project is host to the historic Rottenstone Mine, a high-grade, open pit nickel sulfide past producer that was active from 1965 to 1969 and yielded ~26,000 tonnes of 3.3% Ni, 1.8% Cu, and >9 g/t Pd-Pt+Au.

The geological setting of the Albert Lake Project is within the Trans Hudson Orogeny (Corridor), which is host to numerous world-class nickel mining camps including the Thompson Nickel Belt (currently operating with more than 5 billion pounds of nickel produced since 1959), Lynn Lake (past producer) and Raglan Nickel Belt (currently operating with more than 39,000 tons of nickel produced in 2020).

The project is fully permitted. Exploration plans for 2024 include drilling a high-priority target located approximately 2km south of the historic Rottenstone Mine along with drilling other high-priority targets. Additional soil geochemistry, surface geophysical programs and geological mapping and prospecting will be performed during the summer field season.

The Gochager Lake Project

The Gochager Lake Project in northern Saskatchewan, also in the prolific Trans Hudson Corridor, was recently expanded through the addition of the contiguous Watt’s Lake property and direct staking, bringing its total land area to 22,620 hectares.

The Gochager Lake property is host to a historic resource defined by drilling in 1966-1967 consisting of 4.2 M tons grading 0.29% Ni and 0.08% Cu. Recent drilling by Fathom has defined multiple very robust off-hole borehole electromagnetic (BHEM) responses in eight of nine holes drilled in 2023 and three historic drill holes probed. There is very strong evidence of multiple, high-grade nickel-copper-cobalt steeply oriented chutes within the historic Gochager Lake Deposit.

Prior to Fathom exploration in 2023 and since 1970, exploration at the property has been limited to small drill programs in 1989-1990 and 2018. Exploration plans for 2024 include expanded surface geophysical programs, drilling and continued BHEM surveys to expand tons and increase the grade of the historic Gochager Lake deposit. Summer exploration will consist of soil geochemistry, mapping, prospecting and additional surface geophysical programs focused on identifying other Gochager-like deposits within the current land package.

Market Opportunity

Nickel plays a crucial role in clean energy technologies, and that is expected to cause demand to well outstrip supply for the foreseeable future.

With an annual market value of around $35 billion, nickel demand is projected to rise due to its intensive use in lithium-ion batteries used to power EVs. However, new discoveries of nickel sulfide deposits (currently the most reliable source for battery-grade class 1 nickel) have been rare, which could constrain class 1 nickel supply in the coming years.

According to Deloitte’s global EV forecast, total EV sales will grow from 2.5 million in 2020 to 11.2 million in 2025, reaching 31.1 million by 2030 and representing approximately 32% of the total market share for new car sales. Over the next 10 years, the EV market is projected to see a CAGR of 29%, with increased demand for nickel expected to be comparable.

Management Team

Fathom Nickel has assembled a best-in-class leadership team consisting of highly qualified industry professionals with deep knowledge and understanding of the mineral exploration industry and capital markets.

Ian Fraser, P.Geo., is CEO, VP Exploration and Co-Founder of Fathom Nickel. He has more than 35 years of experience in mineral exploration, as well as managing and implementing exploration projects in Canada and internationally. His experience includes resource interpretation and development of the Casa Berardi Gold Mine and Komis Gold Mine, as well as the Cisneros Gold Mine in Colombia.

Doug Porter, CPA, CA, CBV, is President, CFO and Director of Fathom Nickel. He is a senior financial and accounting executive with specific emphasis in resource company management. His career includes positions with Elan Coal Ltd., Altitude Resources Ltd. and StimWrx Oilfield Services Ltd.

Fathom Nickel Inc. (OTCQB: FNICF), closed Wednesday's trading session at $0.05275, up 2.8265%, on 79,796 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.04895/$0.2634.

Recent News

Coyuchi Inc.

The QualityStocks Daily Newsletter would like to spotlight Coyuchi Inc.

The finance industry in Europe is withstanding pressures to backtrack on its environmental, social and governance ("ESG") investments, with some help from regulations and steady investor demand. In the United States, GOP legislators have successfully diluted regulations that promote ESG, reduced ESG product marketing and discouraged financial companies from working with others to reduce greenhouse-gas emissions. Thus far, Europe has resisted the anti-ESG movement due to consumer support for greener products and regulations supporting operations of companies in the economy, particularly in the finance industry. Some politicians have also helped ease environmental legislations and rules, with investors in Europe injecting even more capital into sustainable fund assets. Despite having considerable opposition to ESG, the U.S. is also home to some companies that are leading the way in making sustainability a hallmark of everything they do. Coyuchi Inc. is an example of companies that are walking the talk of ESG as a cornerstone of their business operations.

Coyuchi is the gold standard in sustainable luxury home goods. The company offers sustainably produced luxury organic bedding, sheets, towels, apparel, and other home goods for the environmentally conscious home. With a timeless, coastal-inspired aesthetic, Coyuchi uses only 100% organic cotton materials to manufacture all of its textiles.

The Company was built upon four foundational pillars: protect the planet, innovate circular design, live sustainably, and enrich the community. These guiding principles have proven an effective market strategy. In 2021, Coyuchi earned $33.3 million in net sales, amounting to 26% YoY growth (the industry average is only 5%). It also experienced 2x customer growth to 200,000 active customers, averaging a 35% customer repeat purchase rate.

With a seasoned leadership team, a robust e-commerce shopping experience, and a healthy customer base that drives the fast-growing organic luxury market, Coyuchi is prepared to propel a new phase of growth as the rest of the world finally awakens to sustainability at scale.

A Lucrative Market Ripe for the Taking

The global market for organic bedding, which was estimated at $814.3 million in 2020, is projected to reach $1.1 billion by 2027, growing at a CAGR of 4.9% over that period, according to Research and Markets. More specifically, the domestic organic bedding market is estimated at $240.1 million in 2020, according to Statista. Overall, the U.S. market for home textiles is currently valued at $25 billion annually, and, with a forecast annual growth rate of 5%, it is expected to reach $30 billion by the end of 2025.

Grand View Research reported in 2020 that shifting consumer preference toward high-end lifestyle products is a key factor driving the growth of the organic bedding market. Seventy-four percent of consumers are willing to pay more for sustainable products – a consumer preference that has steadily increased over the last few decades. Millennials especially favor ethical consumption over price when purchasing goods and services, with 83% of millennials reporting that they want the brands they purchase from to align with their beliefs and values ( With a majority millennial customer base, Coyuchi is poised to capitalize on this trend.

Industry Defining Sustainability Practices

For 30 years, Coyuchi has explored organic farming and sustainable textiles and guarantees the highest environmental and ethical standards through a number of certifications such as The Global Organic Textile Standard (GOTS), Fair Trade Certified, and MADE SAFE®.

Coyuchi continues to push the organic textile market forward through its circularity initiatives and by supporting cross-industry sustainability advocates. Coyuchi’s mission to bring beauty and comfort to every home without sacrificing the health of our planet has resulted in a number of important sustainability checks and balances.

  • A Circular Business Model: Coyuchi has cultivated a holistic 360-degree approach that contributes to the fight against climate change with its take back and recycling program, 2nd Home™. In 2017, it became the first luxury home brand to implement such an initiative, and, since then, the company has eliminated 68,758 lbs. of toxic chemicals from homes and renewed 6,000 lbs. of textiles.
  • The Coyuchi Climate Council: In early 2022, Coyuchi introduced a cross-disciplinary council with a goal of Net Zero Emissions by 2025 and Net Positive Emissions by 2030. The Coyuchi Climate Council brings together influential minds across fashion, regenerative farming, and sustainability who have the knowledge and experience necessary to achieve climate change.
  • C4: The California Cotton & Climate Coalition: Most recently, Coyuchi announced it is a founding member of C4, which includes innovative, sustainable fashion, apparel, and personal care brands like MATE the Label, Outerknown, Reformation, and Trace. Working together pre-competitively, C4 creates a structure for investing in regionally grown, Climate Beneficial™ cotton and directly supports the livelihoods of the farmers that grew it. Coyuchi is the only home industry brand currently involved in the project.

Omnichannel Business Model

Coyuchi differentiates itself through an omnichannel and circular business model, both of which have proven a clear draw for customers. It was an early adopter of an e-commerce sales and marketing approach (over 80% of its sales are directly through, creating a distinct advantage over incumbents and start-up newcomers in the luxury space. This has resulted in a high lifetime value customer, luxury retail partners such as Nordstrom, and a flagship store in Marin County.

Coyuchi’s Organic Textile Products

Coyuchi’s product assortment consists of consciously designed bedding, bath, apparel, and lifestyle products spread across about 1,400 SKUs. The company believes that its product assortment, produced from 100% organic cotton with Global Organic Textile Standard (GOTS) certification, provides it with a significant competitive advantage. GOTS is the world’s leading textile processing standard for organic fibers, ensuring the organic status of textiles after harvesting raw materials through environmentally and socially responsible manufacturing all the way to labeling, a major environmental and social benefit over conventional cotton product production.

Coyuchi’s focused product assortment consists of four core categories:

  • Bedding – A full suite of sustainable, organic, and high-quality sheets, duvet covers, blankets, and throws.
  • Bath – A luxurious line of towels, bath rugs, and mats.
  • Apparel – Premium apparel for men and women, including robes, sweaters, pants, and pajamas.
  • Lifestyle – The lifestyle category offers 135 SKUs, from organic napkins to crossbody totes.

Management Team

Eileen Mockus is President and CEO at Coyuchi. She has more than 25 years of experience in retail, having held positions in textile development at Patagonia, Pottery Barn Teen, and The North Face. She earned a bachelor’s degree in textiles and clothing from UC Davis and an MSBA from San Francisco State University.
Sejal Solanki is Chief Marketing Officer at Coyuchi. She previously served as the company’s Vice President of E-Commerce. Before joining Coyuchi, she worked at teen clothing giant Charlotte Russe. She oversees the company’s digital marketing, site experience, brand marketing, and e-commerce strategy.

Marcus Chung is Coyuchi’s COO, overseeing supply chain, sourcing strategy, sustainability, and IT. He previously held positions at notable direct-to-consumer brands Third Love and Stitch Fix, as well as national retailer The Children’s Place. He holds a bachelor’s degree from Wesleyan University and an MBA from UC Berkeley’s Haas School of Business.

Margot Lyons is Director of Sustainability and Sourcing at Coyuchi, where she works with strategic partners to ensure all the company’s product sustainability standards are met. She received a master’s degree in textiles and clothing from UC Davis.

Use of Proceeds

This round of funding will be used to increase Coyuchi’s enterprise value through expanded marketing, product category expansion, continued physical presence, and B2B strategic partnerships with wholesalers, and online marketplaces.

Recent News


Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

After experiencing unprecedented growth that saw the number of renewable energy projects increase several times over, green-energy projects could potentially face a capital crunch due to high interest rates. Solar and wind project installations may be at an all-time high, but several reputable publications predict that several factors, including high interest rates, could make it difficult for renewable energy projects to access funding and impact green-energy commodity prices in the future. Several years of cost reductions and legislative support, as well as an explosion of investor interest, directed massive investment into green energy and resulted in significant wind- and solar-power development across the globe. Projections from the International Energy Agency show that the world's solar-energy output will continue to rise at an average of 25% annually at least until the end of the decade. The decentralized green-energy generation solutions being commercialized by companies such as Correlate Energy Corp. (OTCQB: CIPI) could come in handy in lowering the cost outlays of setting up new projects geared at availing clean energy.

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Wednesday's trading session at $1.35, even for the day, on 400 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.3501/$2.35.

Recent News

Longeveron Inc. (NASDAQ: LGVN)

The QualityStocks Daily Newsletter would like to spotlight Longeveron Inc. (NASDAQ: LGVN) .

A recently published review has found that social vulnerability and frailty worsen as individuals age. When both are present, these conditions result in a considerably heightened decline in cognitive and physical function as well as mortality risk.

So, what is frailty?

Theoretically, frailty is defined as a state of heightened vulnerability resulting from declines associated with age that is clinically recognizable. These declines often compromise an individual's ability to cope with acute stressors, with researchers noting that frailty is common among older people. While advancements in modern medicine have significantly improved life expectancy of humans beyond natural limits, frailty remains a public health and clinical concern worldwide. Enterprises such as Longeveron Inc. (NASDAQ: LGVN) are focusing on developing treatments targeting people suffering from aging-related frailty so that their quality of life can improve and the additional health risks they face due to frailty can be reduced.

Longeveron (NASDAQ: LGVN) is a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome ("HLHS"), Alzheimer's disease and Aging-related Frailty. The company today announced its entry into definitive agreements for the exercise of certain existing warrants to purchase an aggregate of 2,399,744 shares of its Class A common stock having an exercise price of $2.35 per share, originally issued in October 2023 and April 2024. Gross proceeds to Longeveron from the exercise of the existing warrants are expected to be approximately $6.2 million, prior to deducting placement agent fees and estimated offering expenses payable by the company. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. To view the full press release, visit

Longeveron Inc. (NASDAQ: LGVN) is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. The Company’s research and therapies are aimed at improving the outcome of infants born with a life-threatening heart condition, as well as improving the healthspan for the aging population – the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging, with function and ability to perform activities of daily living.

Longeveron is involved in clinical trials in the following indications: Hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty.

The Company’s philosophy revolves around the idea that regenerative medicine may hold the potential to improve certain rare medical conditions and contribute to healthy aging. While there has been a remarkable rise in life expectancy over the last century due to medical and public health advancements, this increase in longevity has not been paralleled by the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging.

Longeveron’s lead investigational product is Lomecel-B™, an allogeneic Medicinal Signaling Cell therapy product isolated from the bone marrow of young, healthy adult donors. As humans age, they experience a decrease in immune system function, a decline in blood vessel functioning, chronic inflammation, and other issues. Clinical data has suggested that Lomecel-B™ may address these conditions through multiple mechanisms of action (MOA) that simultaneously target key aging-related processes.

The Company is headquartered in Miami, Florida.


Lomecel-B™ is being evaluated in multiple clinical trials for aging-related chronic diseases and other life-threatening conditions under U.S. FDA-approved Investigational New Drug applications. Lomecel-B™ has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas.

The drug is made from special living cells called Medicinal Signaling Cells (MSCs) that are isolated from fresh bone marrow tissue that has been donated by adult donors aged 18 to 45. Once the MSCs have been isolated from the fresh bone marrow through a careful selection process, the cells are culture-expanded (allowed to replicate under controlled laboratory conditions) into the billions using specialized techniques and processes. After a specific number of expansion cycles, called “passages,” the cells are harvested, separated into specific doses (e.g., 50 million cells), and cryopreserved until future use.

These cells have been shown to have characteristics that allow them to be transplanted from a donor to host without triggering a harmful immune response in the recipient, and they can be administered on an outpatient basis in as little as 40 minutes after thawing. Because of these characteristics, Lomecel-B™ is considered an “off-the-shelf” product.

In some trials, such as for Alzheimer’s disease and Aging-related Frailty, Lomecel-B™ is administered via peripheral intravenous infusion, while, in the Company’s HLHS trial, Lomecel-B™ is administered via direct injection into the heart tissue.

Market Opportunity

Longeveron estimates the potential market size for Lomecel-B™ in the treatment of HLHS to be up to $1 billion annually, globally.

U.S. patients suffering from Aging-related Frailty are estimated using U.S. Census Bureau statistics to be approximately 8.1 million. That population potentially represents a market for Lomecel-B™ of between $4 billion and $8 billion globally per year, according to Company estimates.

Additionally, the Alzheimer’s Association puts the number of Americans with that disease at 5.1 million, highlighting another potentially addressable market for Lomecel-B™, that’s worth $5 billion to $10 billion annually.

Management Team

Wa’el Hashad is CEO of Longeveron. He has more than 35 years of experience in the pharmaceutical and biotech industries. He has launched several successful brands in the U.S. and worldwide markets. Prior to joining Longeveron, he was president and CEO of Avanir Pharmaceuticals. Before Avanir, he was the chief commercial officer of Seres Therapeutics. He also has held senior leadership positions at Amgen, Boehringer Ingelheim, and Eli Lilly and Company. He holds a bachelor’s degree in pharmacy from Cairo University and an MBA from the University of Akron.

Joshua M. Hare, M.D., FACC, FAHA, is Co-Founder, Chief Science Officer and Chairman of Longeveron. He is a double board-certified cardiologist and is the founding director of the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine. He is a recipient of the Paul Beeson Physician Faculty Scholar in Aging Research Award and is an elected member of the American Association of Physicians and The American Society for Clinical Investigation. He is also an elected Fellow of the American Heart Association. He received a bachelor’s degree from the University of Pennsylvania and his M.D. from The Johns Hopkins University School of Medicine.

Lisa Locklear is CFO at Longeveron. She previously served as the senior vice president and CFO for Avanir Pharmaceuticals. Prior to Avanir, she held senior financial roles at GSN Games, CoreLogic, Ingram Micro, the Walt Disney Company, and Price Waterhouse, with assignments in Paris and London. She holds a bachelor’s degree in plant science from the University of California, Davis, and an MBA from the University of California, Irvine. She is a licensed CPA (inactive) and is a member of the American Institute of Certified Public Accountants, the California Society of CPAs, and Financial Executives International.

Dr. Nataliya Agafonova, M.D., is the Chief Medical Officer at Longeveron. She previously served as clinical development lead, senior medical director, and product development chair at Otsuka Pharmaceuticals. Before that, she was the clinical development lead and senior medical director at Bristol-Myers Squibb. She previously held senior leadership positions at Ardea Bioscience, Biogen, Amgen, and Genzyme Corporation. She earned an M.D. from the Ukrainian National Medical University and completed her internal medicine residency at Kharkov State University Hospital in Ukraine.

Certain statements in this corporate profile that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which reflect management’s current expectations, assumptions, and estimates of future operations, performance and economic conditions, and involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made herein. Forward-looking statements are generally identifiable by the use of forward-looking terminology such as “believe,” “expects,” “may,” “looks to,” “will,” “should,” “plan,” “intend,” “on condition,” “target,” “see,” “potential,” “estimates,” “preliminary,” or “anticipates” or the negative thereof or comparable terminology, or by discussion of strategy or goals or other future events, circumstances, or effects. Factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements in this release include, but are not limited to, statements regarding the offer and sale of securities, the terms of the offering, about the ability of Longeveron’s clinical trials to demonstrate safety and efficacy of the Company’s product candidates, and other positive results; the timing and focus of the Company’s ongoing and future preclinical studies and clinical trials and the reporting of data from those studies and trials; the size of the market opportunity for the Company’s product candidates, including its estimates of the number of patients who suffer from the diseases being targeted; the success of competing therapies that are or may become available; the beneficial characteristics, safety, efficacy and therapeutic effects of the Company’s product candidates; the Company’s ability to obtain and maintain regulatory approval of its product candidates in the U.S., Japan and other jurisdictions; the Company’s plans relating to the further development of its product candidates, including additional disease states or indications it may pursue; the Company’s plans and ability to obtain or protect intellectual property rights, including extensions of existing patent terms where available and its ability to avoid infringing the intellectual property rights of others; the need to hire additional personnel and the Company’s ability to attract and retain such personnel; the Company’s estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the Company’s need to raise additional capital, and the difficulties it may face in obtaining access to capital, and the dilutive impact it may have on its investors; the Company’s financial performance and ability to continue as a going concern, and the period over which it estimates its existing cash and cash equivalents will be sufficient to fund its future operating expenses and capital expenditure requirements. Additionally, Longeveron makes no assurance that any public offering of its securities as described herein will occur on the timelines, in the manner or on the terms anticipated due to numerous factors. Further information relating to factors that may impact the Company’s results and forward-looking statements are disclosed in the Company’s filings with the Securities and Exchange Commission, including Longeveron’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023 and its Quarterly Report on Form 10-Q for the second quarter of 2023 filed with the SEC on August 11, 2023. The forward-looking statements contained in this corporate profile are made as of the date of this corporate profile, and the Company disclaims any intention or obligation, other than imposed by law, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Investor Contact
Mike Moyer
LifeSci Advisors
Tel: 617-308-4306

Date prepared: August 31, 2023

Longeveron Inc. (NASDAQ: LGVN), closed Wednesday's trading session at $2.09, off by 40.7932%, on 3,380,408 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.62/$44.00.

Recent News


The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

SOBRsafe (NASDAQ: SOBR), providers of next-generation, transdermal alcohol-detection solutions, has signed a hardware/software agreement with a four-facility behavioral health provider in Florida; this agreement is one of sixteen new accounts that SOBRsafe has signed in Q1 2024. According to the announcement, SOBRsafe's SOBRcheck(TM) will replace breathalyzers for frontline screening and allow expanded monitoring abilities for the health provider, which provides a full continuum of care, from inpatient detoxification and residential treatment to outpatient services. The announcement noted that the provider has already installed SOBRcheck in each of its four facilities. "The customer historically used breathalyzers for select check-ins but felt these legacy devices were too inefficient and invasive for uniform entry screening," said SOBRsafe director of commercial development Eddie Kilroy in the press release. "With SOBRcheck, the provider can verify the absence of alcohol in just 10 seconds or less, in a humane and cost-effective manner. The customer is streamlining operations with automatic results reporting, and electronic records searchable by individual and location. Switching to SOBRcheck has empowered them to enhance and expand their screening protocols, while likely reducing attempts to subvert the testing process."

To view the full press release, visit

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.


The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.


With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.


SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.


SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.


Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Wednesday's trading session at $0.2504, off by 0.57574%, on 142,941 volume. The average volume for the last 3 months is 123,511 and the stock's 52-week low/high is $0.2004/$2.33.

Recent News

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF)

The QualityStocks Daily Newsletter would like to spotlight Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF).

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a publicly traded Canadian company in the rare earth element and uranium sectors, has filed an independent technical report for its PCH ionic adsorption clay ("IAC") project located in Goiás, Brazil. The PCH MRE report was prepared in accordance with National Instrument 43-10 ("NI 43-101"). Titled "Technical Report on the Maiden Mineral Resource Estimate for the PCH Project, State of Goiás, Brazil," the report indicated no material differences from results disclosed in the company's press release released last month. The company noted that the report was coauthored by independent qualified persons under NI 43-101, including Yann Camus, Peng; Marc-Antoine Laporte, PGeo, MSc; and Sarah Dean, PGeo. "The PCH MRE Report has outlined both exceptional grade and volume across both Target IV and Buriti zones, which cover a total area of approximately 480 hectares," said Appia Rare Earths & Uranium president Stephen Burega in the press release. "Within Target IV, Appia has identified a high-grade zone with an inferred resource totaling 13.5 Mt at an average grade of 7307 parts per million (‘PPM') TREO. . . . The data generated from the first 300 drill holes at PCH has provided our team with a strong geological signature to track and confirm additional high-grade mineralization at newly identified ionic adsorption clay targets across the remaining tenements, which encompass a very large area of over +40,000 hectares. The phase II auger drilling program is currently well underway, and we look forward to reporting on results as data becomes available."

To view the full press release, visit

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) is a mineral exploration company focused on exploration activities at its newly acquired Cachoeirinha rare earths project (“PCH Project”) in Brazil, as well as delineating high-grade critical rare earth elements (REE) and gallium at its Alces Lake property in Saskatchewan. Other properties in Appia’s portfolio include its Elliot Lake Property in Ontario’s historic mining camp, with a large NI 43-101 uranium and rare earths resource. Fully funded with over $5 million (CDN) in cash, no debt, aggressive exploration currently underway, and experienced management, Appia is progressing rapidly on multiple fronts in highly desired market sectors.

The company is headquartered in Toronto, Canada.


PCH Project-Brazil

The PCH project hosts REE mineralization in both ionic clays developed from the weathering of alkaline granites and in-situ rare earth mineralization associated with the underlying granite and a carbonatite intrusion to depths greater than 100 meters. Sampling data shows enrichment in rare earth minerals to depths of between eight meters and +30 meters.

In early 2023, Appia announced a definitive agreement to acquire a 70% interest in the PCH Project, which is 17,551 hectares in size and located in the Tocantins Structural Province of the Brasília Fold Belt, Goiás State, Brazil. It is classified as an alkaline intrusive rock occurrence with the potential for highly anomalous REE and Niobium mineralization.

The region around Iporá, a city located roughly 30 km from the PCH Project, has significant mineral exploration and mining activity and well-developed infrastructure.

In July 2023, Appia commenced an aggressive auger and reverse circulation (RC) drill campaign to delineate a potential resource estimate at the PCH project. Initial results at the site revealed significant exploration potential with impressive values that often surpass known ionic clay deposits in Brazil, particularly for the highly valuable heavy rare earths Terbium and Dysprosium.

The auger holes drilled at Target 4 have exhibited a range of total REE grades, ranging from 274 ppm to 16,648 ppm (1.66%), with an average of 1,291 ppm total REE. The valuable rare earths used in magnet applications – praseodymium, neodymium, terbium and dysprosium (Pr, Nd, Tb, and Dy) plus yttrium (Y) accounted for approximately 14% of total rare earths, reaching a maximum of 28.4%. Notably, the deposit also contains anomalous values of niobium and scandium, with average values of 736 ppm for Nb and 62 ppm for scandium in a composite sample from Target 4.

Heavy rare earths (HREEs) show maximum values of 1,624 ppm and average values of 1,291 ppm, primarily as terbium and dysprosium. Light rare earths (LREEs) show maximum values of 14,024 ppm (1.54%) with an average of 1,145 ppm. Neodymium and praseodymium, the main magnetic light rare earths, show respective maximum values of 3,131 ppm (Nd) and 885 ppm (Pr) and average values of 216 ppm (Nd) and 61.7 ppm (Pr). The overall HRRE/LREE ratio has a maximum of 39.5% and an average value of 16.67%.

“Appia is thrilled with the progress made and the promising results thus far,” CEO Tom Drivas stated in a news release. “The company remains committed to advancing its exploration plans, aiming to promptly gather significant data throughout the year, and to work towards estimating a maiden mineral resource in the coming months.”

Alces Lake Project – Saskatchewan

Appia’s Alces Lake project, located in northern Saskatchewan, encompasses some of the highest-grade total and critical REEs and gallium mineralization in the world, hosted within several surface and near-surface monazite occurrences that remain open at depth and along strike.

Following the company’s acquisition of additional new mineral claims in the area in February 2023, Appia’s Alces Lake claim block now totals 38,522 contiguous hectares (95,191 acres) – 100% owned by the Company.

Appia announced the completion of a NI43-101 technical report on the property in June 2023, providing an update on exploration previously reported in March 2021.The report is available on SEDAR under the company’s profile.

Extensive diamond drilling and geophysics surveys are underway to explore a more than 25-kilometer structural corridor. In July 2023, the company issued an update on its diamond drill program having completed the first phase of drilling at the project’s Magnet Ridge Zone to further test the extent of the mineralization to the south south-east (SSE). President Stephen Burega noted the presence of “continued mineralization at significantly thicker intercepts.”

As part of its 2023 exploration program at Alces Lake, Appia plans to target priority areas that extend SSE from the Wilson, Richard, Charles, Bell, Ivan, Dylan, Dante and AMP zones through the Magnet Ridge Zone and beyond, covering an area extending approximately 20 kilometers in length and 5 to 7 km in width. Appia will also undertake reconnaissance drilling on priority regional geological and geophysical targets in the Western Anomaly area.

Other Projects

  • Appia holds a total of 75,314 hectares (186,106 acres) of land on four uranium claim blocks in the prolific Athabasca Basin (Loranger, North Wollaston, Eastside and Otherside). Exploration plans for these properties are expected to be announced once permits are in hand.
  • Appia also has a 100% interest in 12,545 hectares (31,000 acres), with rare earth element and uranium deposits over five mineralized zones, in the Elliot Lake Camp, Ontario.

Market Opportunity

A report from Mordor Intelligence forecasts the global REE market is expected to grow from 168 million tons in 2023 to 206.25 million tons by 2028, marking a CAGR of 4.19% during the forecast period. The market is gradually improving following the economic and production restrictions of the COVID-19 pandemic.

Factors driving the market’s growth include high demand from emerging economies and the dependency of environmentally friendly technologies on rare earth elements.

According to UxC, one of the nuclear industry’s leading market research and analysis companies, the uranium market is rapidly becoming production-driven, where spot and long-term prices more closely correlate to the marginal cost of uranium production.

Although global reactor requirements are projected to be flat through 2024, UxC forecasts that significant demand growth from 2025 to 2040 will necessitate new production as resources are exhausted at several uranium projects. In addition, a large percentage of production exists in regions of the world with high geopolitical risk, which makes the market vulnerable to future disruptions and price volatility.

Management Team

Tom Drivas is CEO of Appia Rare Earths & Uranium Corp. He is an entrepreneur with over 30 years of experience in various industries, including over 20 years in the mineral resource industry. He is also currently a director of Romios Gold Resources Inc., a publicly traded company he founded in 1995.

Stephen Burega is President of Appia. He brings 16 years of management and operations experience in the mining and natural resources sectors. His extensive emerging markets background, along with a deep understanding of stakeholder management, social development and structured community engagement, position him well to lead Appia’s First Nations community engagements. He is also President and CEO of Romios Gold Resources which is focused on base and precious metal exploration in North America.

Frank van de Water is the company’s CFO. He holds CPA and CA designations and has been involved with international mining, metals and resource companies in North America, Latin America, Europe and Africa for more than 40 years.

Dr. Irvine R. Annesley, Ph.D., is VP Exploration at Appia. He is a licensed geoscientist (P.GEO.) and Professor in Economic (Mining and Mineral Exploration) Geology at École Nationale Supérieure de Géologie in France and an Adjunct Professor in Geology at the University of Saskatchewan. He has over 35 years of global exploration and applied research experience in uranium, gold and base metals exploration, most recently with Athabasca uranium explorer JNR Resources Inc.

Don Hains, P.Geo., is the company’s Consulting Geologist and Qualified Person Consulting Industrial Minerals Expert.

Antonio Vitor is Appia’s Country Manager, Brazil. He has a track record as a portfolio manager and board member. He has held multiple significant positions, including Territory Manager at Shell, as well as Senior Project Planning and Consulting roles at PwC and Petrobras.

Jack Lifton is the company’s Senior Technical Advisor and Consultant. He is an author and lecturer on the market fundamentals of technology metals.

Appia Rare Earths & Uranium Corp. (OTCQX: APAAF), closed Wednesday's trading session at $0.0889, off by 7.9939%, on 427,346 volume. The average volume for the last 3 months is 176,195 and the stock's 52-week low/high is $0.075/$0.2224.

Recent News

Mountain Top Properties Inc. (OTC: MTPP)

The QualityStocks Daily Newsletter would like to spotlight Mountain Top Properties Inc. (OTC: MTPP).

Mountain Top Properties Inc. (OTC: MTPP) is a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships. The company specializes in property management, property technology (“PropTech”) and real estate redevelopment.

Mountain Top Properties was incorporated in 1990 and is based in Liverpool, New York, with offices in Sag Harbor, New York.


The company’s flagship subsidiary is Mountain Top Realty Inc., the managing partner of its first real estate fund focused on residential redevelopment in the prestigious and storied Hamptons, New York, beachfront communities.

Mountain Top Properties is also the lead investor in blockchain-enabled industrial and warehouse flex space HQXpress, which services the warehousing, reverse logistics and liquidation markets.

The company is in negotiations for the addition of AI-powered technologies that promise to simplify real estate services, including purchasing and sales.

Mountain Top Capital Fund I LLC

Mountain Top Capital Fund I LLC is a New York limited liability company recently organized by affiliates of Mountain Top Realty, manager of the fund. Through this fund, Mountain Top Realty will leverage the company’s experience, market conditions and industry relationships to capitalize on real estate projects as they arise.

This partnership will be focused on waterfront or water view properties in the Hamptons. The Hamptons market has historically remained strong and continues to set new highs year over year.

The fund has partnered with On Site Builder Construction Co. Inc., which is managed by Joseph Kelley, who, for over 40 years, has continued to build the highest quality architecturally designed custom houses, varying in style from classic to ultra-modern, in the Hamptons. Several houses he has built are showcased in books and magazines and featured across various forms of digital and social media. His assembled team of skilled subcontractors are among the finest skilled craftsmen in their various fields of expertise.

Mr. Kelley has built over 60 custom homes in this market and has the unique distinction of building the most expensive house sold in Sag Harbor in 2014, which sold for $31,750,000; the most expensive house in the Hamptons in 2019, which first sold for $27,500,000 in 2017 and later was renovated and re-traded for $39,250,000; and the most expensive house sold in the Hamptons in 2022, which sold with the neighboring house for $118,500,000. Mr. Kelley’s portfolio of projects is valued at over $400,000,000. Although he has historically worked as a custom home builder, he would like to shift from providing a service to now providing a finished product in this market.

Market Opportunity

Mountain Top Capital Fund I has a target to raise $75 million to acquire, renovate and remarket Hamptons waterfront or water view properties. The fund has secured debt capital commitments for 70% of the acquisition costs and 100% of the construction costs and will use $10 million to leverage strategic waterfront opportunities in and around the Hamptons.

Profits from each project will be distributed upon the sale of the project, which is anticipated every 15 to 18 months, with a target of a minimum return on investment of 20% to 30% per transaction.

The company anticipates the fund’s Hamptons projects will be followed up by several other funds targeting additional high-end markets.

Management Team

Beau Kelley is CEO, President, CFO and Director of Mountain Top Properties.

Mountain Top Properties Inc. (OTC: MTPP), closed Wednesday's trading session at $0.026, even for the day. The average volume for the last 3 months is 5,668 and the stock's 52-week low/high is $0.0085/$0.1898.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.